** Shares of healthcare firm PACS Group fall 30.7% to $29.74
** Hindenburg Research says its five-month investigation revealed that "PACS' 'turnaround' strategy largely boils down to systematically scamming taxpayer-funded healthcare programs"
** The short-seller alleges, citing its investigation, that PACS abused a COVID-era waiver, inappropriately accessing skilled care Medicare benefits for thousands of patients across its national portfolio of facilities
** Hindenburg Research says it believes PACS risks significant regulatory penalties
** PACS Group did not immediately respond to a Reuters request for comment
** Up to last close, stock more than doubled since debut on April 11
(Reporting by Jaspreet Singh in Bengaluru)
((Jaspreet.Singh@thomsonreuters.com ; ))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。